Compositions and methods of making rapidly dissolving lonically masked formulations

Abstract

The present invention includes compositions and methods for reduce the taste of the drug in the drug resin complex. The composition may include one or more drug-resin complexes and a highly compressible, free-flowing pharmaceutical excipient. The resin is present in an amount effective to reduce the taste of the drug in the drug resin complex relative to an otherwise identical pharmaceutical composition without the resin; and wherein the highly compressible, free-flowing pharmaceutical excipient causes release of the drug-resin complex in the mouth.

Description

FIELD OF INVENTION [0001] The invention relates to compositions and methods of making rapidly disintegrating or chewable, sustained-release formulations, and more particularly, to compositions and methods for making rapidly disintegrating ionically masked formulations. BACKGROUND OF THE INVENTION [0002] Without limiting the scope of the invention, its background is described in connection with ionically masked pharmaceutical agents that are rapidly disintegrating and delivered in an extended or sustained-release form, as an example. [0003] Methods for sustained release are known in the art. One such method of making sustained release particles is taught in U.S. Pat. No. 6,120,787, issued to Gustafsson, et al., which teach a method for preparing parenterally administrable sustained release microparticles. The method includes preparing core particles in an aqueous medium that is essentially free from organic solvent and the biologically active substance is entrapped therein during or ...

AI Technical Summary

Benefits of technology

[0020] The present invention also includes those chewable formulations made by the methods disclosed and claimed herein. For example, specific chewable formulation may include one or more active agents available for immediate, modified and/or extended or controlled release for use in treating cold/cough/allergy sympt

Problems solved by technology

Many children and adults fail to comply with dosing instructions due to the size, shape, taste and / or mouth-feel of, e.g., tablets, caplets and even gelcaps.

Finally, it was recognized that despite many decades of research and development, controlled-release formulations have not been amenable to large-scale production in facilities and to amounts that are permissible for industrial applicability of controlled-release chewable formulations.

However, despite the many known techniques for eliminating the problems commonly associated with the manufacture of chewable formulations, and hence their widespread failure, none of these formulations have solves the problems of patient compliance due to taste and mouth feel.